1. Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med.341, 1725-1730, http://doi.org/10.1056/NEJM199912023412303 (1999).
2. Howard, K. et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton)14, 123-132, http://doi.org/10.1111/j.1440-1797.2008.01073.x (2009).
3. Tonelli, M. et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am. J. Transplant.11, 2093-2109, http://doi.org/10.1111/j.1600-6143.2011.03686.x (2011).
4. Burdick, J. F. et al. Renal allograft infiltrate in the absence of rejection. Transplant. Proc.16, 1580-1582 (1984).
5. Rush, D. N., Henry, S. F., Jeffery, J. R., Schroeder, T. J. & Gough, J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation57, 208-211, http://doi.org/10.1097/00007890-199401001-00009 (1994).
6. Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant.8, 753-760, http://doi.org/10.1111/j.1600-6143.2008.02159.x (2008).
7. Nankivell, B. J. et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation78, 242-249, http://doi.org/10.1097/01.tp.0000128167.60172.cc (2004).
8. Shapiro, R. et al. An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am. J. Transplant.1, 47-50, http://doi.org/10.1034/j.1600-6143.2001.010109.x (2001).
9. Shishido, S. et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J. Am. Soc. Nephrol.14, 1046-1052, http://doi.org/10.1097/01.asn.0000056189.02819.32 (2003).
10. Wu, O., Levy, A. R., Briggs, A., Lewis, G. & Jardine, A. Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation87, 1330-1339, http://doi.org/10.1097/TP.0b013e3181a236e0 (2009).
11. Moreso, F. et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation93, 41-46, http://doi.org/10.1097/TP.0b013e31823bb647 (2012).
12. El Ters, M. et al. Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am. J. Transplant.13, 2334-2341, http://doi.org/10.1111/ajt.12370 (2013).
13. Cosio, F. G., El Ters, M., Cornell, L. D., Schinstock, C. A. & Stegall, M. D. Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies. Am. J. Transplant.16, 194-203, http://doi.org/10.1111/ajt.13423 (2016).
14. Legendre, C., Canaud, G. & Martinez, F. Factors influencing long-term outcome after kidney transplantation. Transpl. Int.27, 19-27, http://doi.org/10.1111/tri.12217 (2014).
15. Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med.349, 2326-2333, http://doi.org/10.1056/NEJMoa020009 (2003).
16. Rush, D. et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J. Am. Soc. Nephrol.9, 2129-2134, http://doi.org/10.1681/ASN.V9112129 (1998).
17. Choi, B. S. et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am. J. Transplant.5, 1354-1360, http://doi.org/10.1111/j.1600-6143.2005.00830.x (2005).
18. Tanabe, T. The value of long-term protocol biopsies after kidney transplantation. Nephrology (Carlton)19 Suppl 3, 2-5, http://doi.org/10.1111/nep.12253 (2014).
19. Henderson, L. K., Nankivell, B. J. & Chapman, J. R. Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice. Am. J. Transplant.11, 1570-1575, http://doi.org/10.1111/j.1600-6143.2011.03677.x (2011).
20. Roufosse, C. et al. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation102, 1795-1814, http://doi.org/10.1097/TP.0000000000002366 (2018).
21. Inker, L. A. et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney Dis.63, 713-735, http://doi.org/10.1053/j.ajkd.2014.01.416 (2014).
22. Sakai, K., Oguchi, H., Muramatsu, M. & Shishido, S. Protocol graft biopsy in kidney transplantation. Nephrology (Carlton)23 Suppl 2, 38-44, http://doi.org/10.1111/nep.13282 (2018).
23. Mehta, R., Sood, P. & Hariharan, S. Subclinical Rejection in Renal Transplantation: Reappraised. Transplantation100, 1610-1618, http://doi.org/10.1097/TP.0000000000001163 (2016).
24. Arndt, R. et al. Noninvasive evaluation of renal allograft fibrosis by transient elastography--a pilot study. Transpl. Int.23, 871-877, http://doi.org/10.1111/j.1432-2277.2010.01057.x (2010).
25. Chapman, J. R. Do protocol transplant biopsies improve kidney transplant outcomes? Curr. Opin. Nephrol. Hypertens.21, 580-586, http://doi.org/10.1097/MNH.0b013e32835903f4 (2012).
26. Wilkinson, A. Protocol transplant biopsies: are they really needed? Clin. J. Am. Soc. Nephrol.1, 130-137, http://doi.org/10.2215/CJN.00350705 (2006).
27. Furness, P. N. et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation76, 969-973, http://doi.org/10.1097/01.TP.0000082542.99416.11 (2003).
28. Thaunat, O., Legendre, C., Morelon, E., Kreis, H. & Mamzer-Bruneel, M. F. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation84, 671-676, http://doi.org/10.1097/01.tp.0000282870.71282.ed (2007).
29. Morgan, T. A., Chandran, S., Burger, I. M., Zhang, C. A. & Goldstein, R. B. Complications of Ultrasound-Guided Renal Transplant Biopsies. Am. J. Transplant.16, 1298-1305, http://doi.org/10.1111/ajt.13622 (2016).
30. Seok, H. et al. Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients. Eur. J. Clin. Microbiol. Infect. Dis.39, 1543-1550, http://doi.org/10.1007/s10096-020-03871-2 (2020).
31. Gigliotti, P. et al. Early subclinical rejection treated with low dose i.v. steroids is not associated to graft survival impairment: 13-years' experience at a single center. J. Nephrol.29, 443-449, http://doi.org/10.1007/s40620-015-0206-0 (2016).